Drug Markets/Tapentadol Hydrochloride

Tapentadol Hydrochloride

8 NDCs across 1 manufacturer|0 Generic,8 Brand

Tapentadol Hydrochloride is used to treat pain, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Nov 20, 2008, and the first generic was approved Jan 26, 2026. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient.

Tapentadol Hydrochloride is available as 8 NDCs from 1 manufacturer (0 generic, 8 brand), with NADAC prices from $10.15 to $40.19 per EAthe most expensive product costs about 4.0× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

8

0G / 8B

Manufacturers

1

competing in market

Price Spread

$10.15 – $40.19

per EA

7d Activity

8 flat

avg +0.0% WoW · of 8 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing TAPENTADOL HYDROCHLORIDE

Drug Portfolio

8 NDCs total, 8 shown

Frequently Asked Questions

What is Tapentadol Hydrochloride used to treat?

Tapentadol Hydrochloride is used to treat pain, per the National Library of Medicine's MED-RT classification.

When did Tapentadol Hydrochloride become available as a generic?

FDA approved the first generic Tapentadol Hydrochloride (ANDA) on Jan 26, 2026. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How many Tapentadol Hydrochloride products are on the market?

The Tapentadol Hydrochloride drug market contains 8 NDCs from 1 manufacturer — 0 generic and 8 brand products.

What is the price range for Tapentadol Hydrochloride?

NADAC reference prices for Tapentadol Hydrochloride range from $10.1486 to $40.1901 per EA — the most expensive product costs about 4.0× the cheapest.

Which manufacturers make Tapentadol Hydrochloride?

1 manufacturer lists Tapentadol Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Collegium Pharmaceutical, Inc. (8).